Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry
Archives of Iranian Medicine · 2023
DOI: 10.34172/aim.2023.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Iranian Medicine, 2023. Verfasst von Ali Ashkbari und 13 weiteren Autor:innen. Beteiligte Einrichtung: Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran. Hauptthemen laut MEDLINE: Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Epidemiological research on the high-risk population might be helpful in early detection and prevention of biliary tract malignancies. This study assesses the prevalence of biliary tract cancer (BTC) in the Golestan province, northeastern Iran, between 2004 and 2016.
Methods
The current study used information from the Golestan Population-based Cancer Registry (GPCR) to access the epidemiology of BTC across a 13-year period while taking into account temporal and geographic differences. The number of cases, crude rates, age-standardized incidence rates (ASRs) per 100,000 person-years, average annual percent change (AAPC), age-specific incidence rates, and 95% confidence intervals (CI) were reported for each year with respect to gender and place of residence.
Results
Totally, 224 instances of BTC overall (54% of whom were females) were reported throughout the research period. The ASR of BTC was 1.7 (95% CI: 1.4‒2) for females and 1.4 (95% CI: 1.1‒1.6) for men, respectively. Males exhibited a growing time trend in incidence (AAPC: 7.18; CI: 0.06‒14.81; P-value:0.048), whereas females had a decreasing trend (AAPC: 0.82; CI: -5.94‒4.57; P-value: 0.740). Both sexes saw an increase in age-specific incidence rates starting at the age of 45; however, males experienced a significant increase in incidence in the age group of 75 to 79 while the female rates grew steadily.
Conclusion
The focus for cancer control in this region may be given to demographic groups with a combination of risk factors, including male gender, older age, and urban residence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
- Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
- Omid Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
- Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran.
ORCID-Profile: Ali Ashkbari, Alireza Norouzi
Zitieren
APA
Ashkbari, A., Isapanah Amlashi, F., Besharat, S., Mofidi, M., Amiriani, T., Fazel, A., Alimadadi, M., Salamat, F., Sedaghat, S. M., Livani, S., Bagheri, A., Semnani, S., Norouzi, A., & Roshandel, G. (2023). Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry. Archives of Iranian Medicine. https://doi.org/10.34172/aim.2023.76
Vancouver
Ashkbari A, Isapanah Amlashi F, Besharat S, Mofidi M, Amiriani T, Fazel A, et al. Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry. Archives of Iranian Medicine. 2023. doi:10.34172/aim.2023.76
BibTeX
@article{Ashkbari2023,
author = {Ashkbari, Ali and Isapanah Amlashi, Fazel and Besharat, Sima and Mofidi, Mostafa and Amiriani, Taghi and Fazel, Abdolreza and Alimadadi, Mehdi and Salamat, Faezeh and Sedaghat, Seyyed Mehdi and Livani, Somayeh and Bagheri, Ali and Semnani, Shahriyar and Norouzi, Alireza and Roshandel, Gholamreza},
title = {Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry},
journal = {Archives of Iranian Medicine},
year = {2023},
doi = {10.34172/aim.2023.76}
}
EUVIMED